LEXX logo

Lexaria Bioscience (LEXX) Current Liabilities

Annual Current Liabilities

$1.10 M
+$831.70 K+310.68%

August 31, 2024


Summary


Performance

LEXX Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLEXXbalance sheetmetrics:

Quarterly Current Liabilities

$297.80 K
-$801.60 K-72.91%

November 30, 2024


Summary


Performance

LEXX Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLEXXbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

LEXX Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+310.7%0.0%
3 y3 years+617.2%+5.8%
5 y5 years+495.9%+5.8%

LEXX Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+617.2%-72.9%+264.5%
5 y5-yearat high+617.2%-72.9%+370.5%
alltimeall time-45.4%+9716.1%-85.2%+1467.4%

Lexaria Bioscience Current Liabilities History

DateAnnualQuarterly
Nov 2024
-
$297.80 K(-72.9%)
Aug 2024
$1.10 M(+310.7%)
$1.10 M(+604.7%)
May 2024
-
$156.00 K(+90.9%)
Feb 2024
-
$81.70 K(-34.4%)
Nov 2023
-
$124.50 K(-53.5%)
Aug 2023
$267.70 K(+38.0%)
$267.70 K(-74.6%)
May 2023
-
$1.06 M(+373.3%)
Feb 2023
-
$223.10 K(-20.7%)
Nov 2022
-
$281.50 K(+45.1%)
Aug 2022
$194.00 K(+26.5%)
$194.00 K(-6.2%)
May 2022
-
$206.80 K(+25.0%)
Feb 2022
-
$165.50 K(-30.4%)
Nov 2021
-
$237.70 K(+55.1%)
Aug 2021
$153.30 K(-32.1%)
$153.30 K(-30.7%)
May 2021
-
$221.20 K(-44.6%)
Feb 2021
-
$399.40 K(+64.7%)
Nov 2020
-
$242.50 K(+7.3%)
Aug 2020
$225.90 K(+22.4%)
$225.90 K(+148.2%)
May 2020
-
$91.00 K(+43.8%)
Feb 2020
-
$63.30 K(-51.4%)
Nov 2019
-
$130.20 K(-29.4%)
Aug 2019
$184.50 K(+323.2%)
$184.50 K(+39.5%)
May 2019
-
$132.30 K(-73.5%)
Feb 2019
-
$500.10 K(+285.0%)
Nov 2018
-
$129.90 K(+197.9%)
Aug 2018
$43.60 K(-52.8%)
$43.60 K(-39.1%)
May 2018
-
$71.60 K(+3.8%)
Feb 2018
-
$69.00 K(-27.9%)
Nov 2017
-
$95.70 K(+3.7%)
Aug 2017
$92.30 K(-78.7%)
$92.30 K(+130.8%)
May 2017
-
$40.00 K(-88.0%)
Feb 2017
-
$333.50 K(-28.8%)
Nov 2016
-
$468.60 K(+8.0%)
Aug 2016
$433.90 K(+687.5%)
$433.90 K(+30.9%)
May 2016
-
$331.50 K(+16.6%)
Feb 2016
-
$284.30 K(+60.3%)
Nov 2015
-
$177.40 K(+222.0%)
Aug 2015
$55.10 K
$55.10 K(-12.0%)
May 2015
-
$62.60 K(+64.3%)
DateAnnualQuarterly
Feb 2015
-
$38.10 K(-95.2%)
Nov 2014
-
$789.40 K(-17.5%)
Aug 2014
$918.00 K(-35.1%)
-
Jul 2014
-
$957.40 K(-8.4%)
Apr 2014
-
$1.05 M(-29.0%)
Jan 2014
-
$1.47 M(+4.1%)
Oct 2013
$1.42 M(-17.3%)
$1.42 M(+1.2%)
Jul 2013
-
$1.40 M(-5.4%)
Apr 2013
-
$1.48 M(-4.9%)
Jan 2013
-
$1.55 M(-9.1%)
Oct 2012
$1.71 M(+58.7%)
$1.71 M(-6.8%)
Jul 2012
-
$1.84 M(+1.4%)
Apr 2012
-
$1.81 M(+8.0%)
Jan 2012
-
$1.68 M(+55.4%)
Oct 2011
$1.08 M(+2.8%)
$1.08 M(+23.0%)
Jul 2011
-
$876.70 K(-10.6%)
Apr 2011
-
$980.60 K(+0.8%)
Jan 2011
-
$972.80 K(-7.3%)
Oct 2010
$1.05 M(+1.8%)
$1.05 M(-7.8%)
Jul 2010
-
$1.14 M(+4.4%)
Apr 2010
-
$1.09 M(+2.7%)
Jan 2010
-
$1.06 M(+2.9%)
Oct 2009
$1.03 M(+272.4%)
$1.03 M(+3929.3%)
Jul 2009
-
$25.60 K(-66.3%)
Apr 2009
-
$75.90 K(+299.5%)
Jan 2009
-
$19.00 K(-93.1%)
Oct 2008
$277.00 K(-30.9%)
$277.00 K(-64.1%)
Jul 2008
-
$772.30 K(+1.5%)
Apr 2008
-
$760.80 K(-14.1%)
Jan 2008
-
$885.80 K(+120.9%)
Oct 2007
$401.00 K(-80.1%)
$401.00 K(-22.0%)
Jul 2007
-
$514.30 K(+419.0%)
Apr 2007
-
$99.10 K(+378.7%)
Jan 2007
-
$20.70 K(-99.0%)
Oct 2006
$2.01 M(>+9900.0%)
$2.01 M(+8365.1%)
Jul 2006
-
$23.80 K(-16.2%)
Apr 2006
-
$28.40 K(+6.0%)
Jan 2006
-
$26.80 K
Oct 2005
$11.20 K
-

FAQ

  • What is Lexaria Bioscience annual total current liabilities?
  • What is the all time high annual current liabilities for Lexaria Bioscience?
  • What is Lexaria Bioscience annual current liabilities year-on-year change?
  • What is Lexaria Bioscience quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Lexaria Bioscience?
  • What is Lexaria Bioscience quarterly current liabilities year-on-year change?

What is Lexaria Bioscience annual total current liabilities?

The current annual current liabilities of LEXX is $1.10 M

What is the all time high annual current liabilities for Lexaria Bioscience?

Lexaria Bioscience all-time high annual total current liabilities is $2.01 M

What is Lexaria Bioscience annual current liabilities year-on-year change?

Over the past year, LEXX annual total current liabilities has changed by +$831.70 K (+310.68%)

What is Lexaria Bioscience quarterly total current liabilities?

The current quarterly current liabilities of LEXX is $297.80 K

What is the all time high quarterly current liabilities for Lexaria Bioscience?

Lexaria Bioscience all-time high quarterly total current liabilities is $2.01 M

What is Lexaria Bioscience quarterly current liabilities year-on-year change?

Over the past year, LEXX quarterly total current liabilities has changed by $0.00 (0.00%)